← SynDRA
asymmetrical-dimethylarginine
SynDRA canonical compound SYN0087348 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | NOS3 |
| Mechanism of action | Dimethylarginine dimethylaminohydrolase inhibitor |
All known targets
Mechanisms of action (all sources)
- Nitric oxide synthase inhibitor
- Dimethylarginine dimethylaminohydrolase inhibitor
- NOS2 INHIBITOR
- NOS3 INHIBITOR
Cross-references
Synonyms
- N,N-Dimethylarginine
- ADMA
- Asymmetric dimethylarginine
- Dimethyl-L-arginine
- NG,NG-dimethyl-L-arginine
- N(G)-Dimethylarginine
- N(G),N(G)-Dimethylarginine
- Guanidino-N,N-dimethylarginine
- N(G1),N(G1)-Dimethylarginine
- N(5)-((Dimethylamino)iminomethyl)-L-ornithine
- L-NG,NG-dimethylarginine
- CHEBI:17929
- (2S)-2-amino-5-(1,1-dimethylcarbamimidamido)pentanoic acid
- N(5)-[(dimethylamino)(imino)methyl]-L-ornithine
- N(5)-((dimethylamino)(imino)methyl)-L-ornithine
- RefChem:560286
- DTXCID4016758
- Guanidino-N(1),N(1)-Dimethylarginine
- L-Ornithine, N5-((dimethylamino)iminomethyl)-
- (S)-2-Amino-5-(3,3-dimethylguanidino)pentanoic acid
- NG,NG-dimethylarginine
- MFCD00038406
- N(omega),N(omega)-dimethyl-L-arginine
- NG,NG-dimethyl-L-Arginine (hydrochloride)
- NG,NG-DIMETHYLARGININE HYDROCHLORIDE
- N~5~-(N,N-dimethylcarbamimidoyl)-L-ornithine
- Lopac-D-4268
- UNII-63CV1GEK3Y
- Nomega,Nomega-Dimethyl-L-arginine
- NG-dimethylarginine
- L-Arg(Me, Me)-OH (asymmetrical)
- n-n-dimethylarginine
- N5-[(Dimethylamino)iminomethyl]-L-ornithine
- Assymetric Dimethylarginine
- Lopac0_000388
- ADMA, 3
- N,N-DIMETHYL-ARGININE
- SCHEMBL196828
- SCHEMBL995818
Look up asymmetrical-dimethylarginine in the interactive SynDRA portal →